[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100586973":3},{"organization":4,"outcomesModule":7,"designInfo":14,"detailedDescription":22,"studyPopulation":13,"armGroups":23,"interventions":35,"overallOfficials":13,"centralContacts":13,"locations":45,"responsibleParty":65,"collaborators":13,"id":68,"slug":13,"hasResults":69,"nctId":70,"briefTitle":71,"officialTitle":71,"acronym":13,"eligibilityCriteria":72,"healthyVolunteers":69,"sex":73,"minAge":74,"maxAge":75,"enrollmentInfo":76,"targetDuration":13,"studyType":79,"phases":80,"briefSummary":82,"conditions":83,"keywords":85,"overallStatus":47,"whyStopped":13,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"Khyber Teaching Hospital","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":13},[9],{"measure":10,"description":11,"timeFrame":12},"Efficacy of Treatment","Efficacy of treatment is defined by absence of scaling by naked eye examination ,absence of yellow or golden scale reflection on woods lamp examination and absence of fungal hyphae on microscopic examination.","Upto 8 weeks",null,{"allocation":15,"interventionModel":16,"interventionModelDescription":13,"primaryPurpose":17,"observationalModel":13,"timePerspective":13,"maskingInfo":18},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":19,"maskingDescription":13,"whoMasked":20},"SINGLE",[21],"PARTICIPANT","Pityriasis versicolor is a common fungal infection of the superficial skin layers. Avalible treatment options include topical and systemic drugs. fluconazole and itraconazole are commonly used systemic agents. The aim of this study is to compare the efficacy of the two systemic drugs.",[24,30],{"label":25,"type":26,"description":27,"interventionNames":28},"Group A, Fluconazole group","EXPERIMENTAL","Group A consists of patients in whom oral fluconazole is given in dose of 300mg once weekly for 2 weeks.",[29],"Drug: Fluconazole",{"label":31,"type":26,"description":32,"interventionNames":33},"Group B, Itraconazole group","Group B consists of patients in whom oral Itraconazole is given in dose of 100mg Twice for 5 days.",[34],"Drug: Itraconazole",[36,41],{"type":37,"name":38,"description":39,"armGroupLabels":40,"otherNames":13},"DRUG","Fluconazole","Oral fluconazole prescribed to group A",[25],{"type":37,"name":42,"description":43,"armGroupLabels":44,"otherNames":13},"Itraconazole","Oral itraconazole prescribed to Group B",[31],[46],{"facility":5,"status":47,"city":48,"state":49,"zip":50,"country":51,"countryCode":52,"cosmosGeoPoint":53,"geoPoint":58,"contacts":59},"RECRUITING","Peshawar","KPK","25000","Pakistan","PK",{"type":54,"coordinates":55},"Point",[56,57],71.57849,34.008,{"lat":57,"lon":56},[60],{"name":61,"role":62,"phone":63,"phoneExt":13,"email":64},"Hajira Amin","CONTACT","0346 9075951","info@kth.edu.pk",{"type":66,"investigatorFullName":61,"investigatorTitle":67,"investigatorAffiliation":5,"oldNameTitle":13,"oldOrganization":13},"PRINCIPAL_INVESTIGATOR","Doctor","100586973",false,"NCT06922344","Comparison of Efficacy of Oral Fluconazole Versus Oral Itraconazole in the Treatment of Pityriasis Versicolor","Inclusion Criteria:\n\n* All cases of Pityriasis versicolor\n\nExclusion Criteria:\n\n* Patients with history of chronic renal or liver disease, malignancy , or undergoing any kind of chemotherapy or radiotherapy or having cardiac conduction abnormalities.\n* Patients who received any anti-fungal therapy in the last one month.\n* Pregnant or lactating women.","ALL","18 Years","50 Years",{"count":77,"type":78},106,"ESTIMATED","INTERVENTIONAL",[81],"PHASE4","This study compares the efficacy of two drugs, namely flucanazole and itraconazole for the treatment of a common fungal infection of skin.",[84],"Pityriasis Versicolor",[84,38,42],"2025-04-09",{"date":88,"type":89},"2025-04-10","ACTUAL",{"date":91,"type":89},"2025-03-01",{"date":93,"type":78},"2025-12-31",{"name":5,"class":6},1]